PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
INSULET CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$141.96+0.86 (+0.61%)
Close on Oct 19, 2026
- Market cap
- $9.85B
- P/E (TTM)
- 26.5
- Dividend yield
- –
Share price
−$176.63 (−55.44%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
INSULET CORP grew revenue 29.4% to $3.05B over the twelve months to Jun 30, 2026. Operating income rose 26.6% to $515.80M, moving the operating margin from 17.3% to 16.9%. Free cash flow was $293.70M, down 27.5% from a year earlier.
Revenue
$3.05B
+29.4% vs. a year earlier
Operating income
$515.80M
+26.6% vs. a year earlier
Free cash flow
$293.70M
-27.5% vs. a year earlier
EPS, diluted
$5.35
+64.1% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $9.85B
- P/E ratio
- 26.5
- Price to sales
- 3.23
- Price to book
- 6.93
- Dividend yield
- –
- Free cash flow yield
- 2.98%
Fundamentals
- Revenue
- $3.05B
- Net income
- $375.30M
- EPS, diluted
- $5.35
- Free cash flow
- $293.70M
- Book value per share
- $20.49
- Diluted shares
- 69M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$3.05B+29.4% YoY
Gross profit
$2.17B+30.0% YoY
Operating income
$515.80M+26.6% YoY
Net income
$375.30M+59.0% YoY
EPS, diluted
$5.35+64.1% YoY
Free cash flow
$293.70M-27.5% YoY
Reported periodTrailing twelve months